394 related articles for article (PubMed ID: 26705234)
1. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
Hsiao FC; Tung YC; Chou SH; Wu LS; Lin CP; Wang CL; Lin YS; Chang CJ; Chu PH
Medicine (Baltimore); 2015 Dec; 94(51):e2355. PubMed ID: 26705234
[TBL] [Abstract][Full Text] [Related]
2. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
Simonyi G; Ferenci T; Finta E; Igaz I; Balogh S; Gasparics R; Medvegy M
Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
[TBL] [Abstract][Full Text] [Related]
3. [One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients].
Simonyi G; Ferenci T; Finta E; Medvegy M; Wittmann I
Orv Hetil; 2023 Aug; 164(34):1337-1341. PubMed ID: 37634155
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
5. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
6. Medication compliance and clinical outcomes of fixed-dose combinations vs free combinations of an angiotensin II receptor blocker and a calcium channel blocker in hypertension treatment.
Tung YC; Huang YC; Wu LS; Chang CJ; Chu PH
J Clin Hypertens (Greenwich); 2017 Oct; 19(10):983-989. PubMed ID: 28560786
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
Haroon S; Subramanian A; Cooper J; Anand A; Gokhale K; Byne N; Dhalla S; Acosta-Mena D; Taverner T; Okoth K; Wang J; Chandan JS; Sainsbury C; Zemedikun DT; Thomas GN; Parekh D; Marshall T; Sapey E; Adderley NJ; Nirantharakumar K
BMC Infect Dis; 2021 Mar; 21(1):262. PubMed ID: 33722197
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes in hypertensive patients treated with a single-pill fixed-dose combination of renin-angiotensin system inhibitor and thiazide diuretic.
Ho CT; Tung YC; Chou SH; Hsiao FC; Lin YS; Chang CJ; Chu PH
J Clin Hypertens (Greenwich); 2018 Dec; 20(12):1731-1738. PubMed ID: 30375168
[TBL] [Abstract][Full Text] [Related]
10. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
11. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up.
Jeong HS; Lim HS; Park HJ; Lee WS; Choi JO; Lee HS; Jo SH; Hong SJ
Sci Rep; 2021 Jan; 11(1):1783. PubMed ID: 33469103
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC; Heran BS; Wright JM
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Medication Selection Model Under Clinical Application of Renin-Angiotensin Inhibitor Combined with Calcium Channel Blocker for Hypertension Patients.
Hong D; Shi W; Lu X; Lou Y; Li L
Med Sci Monit; 2020 Apr; 26():e923696. PubMed ID: 32285846
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.
Ishida T; Oh A; Hiroi S; Shimasaki Y; Nishigaki N; Tsuchihashi T
Hypertens Res; 2019 Feb; 42(2):249-256. PubMed ID: 30443023
[TBL] [Abstract][Full Text] [Related]
16. A review of chemical therapies for treating diabetic hypertension.
Sarafidis PA; Alexandrou ME; Ruilope LM
Expert Opin Pharmacother; 2017 Jun; 18(9):909-923. PubMed ID: 28480805
[TBL] [Abstract][Full Text] [Related]
17. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Choksi TT; Zhang H; Chen T; Malhotra N
Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
[TBL] [Abstract][Full Text] [Related]
19. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens.
Zeng F; Patel BV; Andrews L; Frech-Tamas F; Rudolph AE
Curr Med Res Opin; 2010 Dec; 26(12):2877-87. PubMed ID: 21067459
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
da Silva PM
Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
